FOSPROPOFOL DISODIUM FOR SEDATION

被引:1
作者
Campion, Megan E. [1 ]
Gan, Tong J. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA
关键词
SEE VOL. 112; WATER-SOLUBLE PRODRUG; MODERATE SEDATION; PG; 1058; DOUBLE-BLIND; GPI; 15715; CONSCIOUS SEDATION; BOLUS INJECTION; PROPOFOL; PHARMACOKINETICS;
D O I
10.1358/dot.2009.45.8.1396674
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The practice of procedural sedation is expanding rapidly because minimally invasive surgery and interventional medical specialties ore replacing conventional surgery, and increasingly these procedures con appropriately be done under sedation rather than general anesthesia. Patients prefer sedation techniques so the procedures con be accomplished with minimal discomfort and they con recover more rapidly and ovoid the potential side effects of general anesthesia. The goals for a sedation technique are to provide sedation, analgesia and, as requested, amnesia. This requires a balance between patient comfort and safety, while preventing cardiovascular or respiratory compromise or delayed recovery. Propofol has been used for over two decades and has many properties ideally suited for procedural sedation. More recently, a new propofol prodrug, fospropofol disodium was also approved in the U.S. as a sedative. Fospropofol is formulated in aqueous solution and has some potential advantages over propofol. This review discusses the pharmacology and clinical uses of propofol and fospropofol, as well as the benefits and disadvantages of the two drugs when used for sedation.
引用
收藏
页码:567 / 576
页数:10
相关论文
共 36 条
[1]   Sedation for gastrointestinal endoscopy: New practices, new economics [J].
Aisenberg, J ;
Brill, JV ;
Ladabaum, U ;
Cohen, LB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (05) :996-1000
[2]  
Clarke JP, 2002, MED J AUSTRALIA, V177, P163
[3]  
*CLINICALTRIALS GO, 2009, CLIN TRIALS FOSPR
[4]   Clinical trial: a dose-response study of fospropofol disodium for moderate sedation during colonoscopy [J].
Cohen, L. B. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (07) :597-608
[5]   Patient and physician satisfaction with fospropofol disodium: Results of a phase 3, randomized, double-blind trial evaluating fospropofol disodium for moderate sedation in patients undergoing colonoscopy [J].
Cohen, Lawrence B. ;
Rex, Douglas K. ;
Kline, Jacqueline ;
Wang, Chao .
GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) :AB367-AB367
[6]   Endoscopic sedation in the United States: Results from a nationwide survey [J].
Cohen, Lawrence B. ;
Wecsler, Julie S. ;
Gaetano, John N. ;
Benson, Ariel A. ;
Miller, Kenneth M. ;
Durkalski, Valerie ;
Aisenberg, James .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (05) :967-974
[7]   Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperldine/fentanyl, and midazolam [J].
Cohen, LB ;
Hightower, CD ;
Wood, DA ;
Miller, KM ;
Aisenberg, J .
GASTROINTESTINAL ENDOSCOPY, 2004, 59 (07) :795-803
[8]   RETRACTED: Sedation with GPI 15715, a water-soluble prodrug of propofol, using target-controlled infusion in volunteers (Retracted article. See vol. 110, pg. 1238, 2010) [J].
Fechner, J ;
Ihmsen, H ;
Schiessl, C ;
Jeleazcov, C ;
Vornov, JJ ;
Schwilden, H ;
Schüttler, J .
ANESTHESIA AND ANALGESIA, 2005, 100 (03) :701-706
[9]   RETRACTED: Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion (Retracted article. See vol. 112, pg. 1058, 2010) [J].
Fechner, J ;
Ihmsen, H ;
Hatterscheid, D ;
Jeleazcov, C ;
Schiessl, C ;
Vornov, JJ ;
Schwilden, H ;
Schüttler, J .
ANESTHESIOLOGY, 2004, 101 (03) :626-639
[10]   RETRACTED: Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers (Retracted article. See vol. 112, pg. 1058, 2010) [J].
Fechner, J ;
Ihmsen, H ;
Hatterscheid, D ;
Schiessl, C ;
Vornov, JJ ;
Burak, E ;
Schwilden, H ;
Schüttler, JR .
ANESTHESIOLOGY, 2003, 99 (02) :303-313